A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.
GlobalData on MSN15d
AerWave Medical concludes study of ultrasound therapy for COPDThe study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
“This first-in-human study underscores the transformative potential of AerWave’s technology to redefine the treatment paradigm for COPD and asthma,” said study investigator Dr. David ...
AerWave Medical has concluded the feasibility study of its ultrasound lung denervation therapy, designed to treat chronic obstructive pulmonary disease (COPD) and asthma. The first-in-human study ...
- Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary ...
- Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical , a leader in ultrasound-based interventional pulmonary solutions, today announced the successful completion of its first-in-human (FIH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback